(Q68328026)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1684442%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

title

Brief neuroleptic discontinuation and clinical symptoms in Kraepelinian and non-Kraepelinian chronic schizophrenic patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1684442%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

1 reference

P. D. Harvey

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1684442

28 October 2022

K. M. Putnam

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1684442

28 October 2022

M. Davidson

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1684442

28 October 2022

R. S. Kahn

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1684442

28 October 2022

P. Powchik

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1684442

28 October 2022

R. McQueeney

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1684442

28 October 2022

R. S. Keefe

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1684442

28 October 2022

K. L. Davis

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1684442

28 October 2022

language of work or name

English

0 references

publication date

1 September 1991

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1684442%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

23 September 2019

https://api.elsevier.com/content/article/PII:016517819190018K?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0165-1781(91)90018-K

https://api.elsevier.com/content/article/PII:016517819190018K?httpAccept=text/plain

28 October 2022

1 reference

https://api.crossref.org/works/10.1016/0165-1781(91)90018-K

28 October 2022

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1684442%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

volume

38

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1684442%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1684442%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

page(s)

285-292

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1684442%20AND%20SRC:MED&resulttype=core&format=json

A diagnostic interview: the schedule for affective disorders and schizophrenia

23 September 2019

cites work

3

1 reference

https://api.crossref.org/works/10.1016/0165-1781(91)90018-K

Time course and clinical predictors of treatment response in schizophrenia

28 October 2022

5

1 reference

https://api.crossref.org/works/10.1016/0165-1781(91)90018-K

Intermittent vs maintenance medication in schizophrenia. Two-year results

28 October 2022

6

1 reference

https://api.crossref.org/works/10.1016/0165-1781(91)90018-K

Intermittent medication for stable schizophrenic outpatients: an alternative to maintenance medication

28 October 2022

7

1 reference

https://api.crossref.org/works/10.1016/0165-1781(91)90018-K

Family psychoeducation, social skills training, and maintenance chemotherapy in the aftercare treatment of schizophrenia. II. Two-year effects of a controlled study on relapse and adjustment. Environmental-Personal Indicators in the Course of Schizo

28 October 2022

8

1 reference

https://api.crossref.org/works/10.1016/0165-1781(91)90018-K

Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine

28 October 2022

9

1 reference

https://api.crossref.org/works/10.1016/0165-1781(91)90018-K

Diagnostic issues in chronic schizophrenia: kraepelinian schizophrenia, undifferentiated schizophrenia, and state-independent negative symptoms.

28 October 2022

10

1 reference

https://api.crossref.org/works/10.1016/0165-1781(91)90018-K

Characteristics of very poor outcome schizophrenia

28 October 2022

12

1 reference

https://api.crossref.org/works/10.1016/0165-1781(91)90018-K

Very high dosage vs standard dosage fluphenazine in schizophrenia. A double-blind study of nonchronic treatment-refractory patients

28 October 2022

15

1 reference

https://api.crossref.org/works/10.1016/0165-1781(91)90018-K

Research diagnostic criteria: rationale and reliability

28 October 2022

17

1 reference

https://api.crossref.org/works/10.1016/0165-1781(91)90018-K

28 October 2022

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1684442%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

1 reference